vs
Apyx Medical Corp(APYX)与3M(MMM)财务数据对比。点击上方公司名可切换其他公司
3M的季度营收约是Apyx Medical Corp的314.7倍($6.0B vs $19.2M)。3M净利率更高(10.8% vs -6.8%,领先17.6%)。Apyx Medical Corp同比增速更快(34.7% vs 1.3%)。3M自由现金流更多($2.0B vs $-2.8M)。过去两年Apyx Medical Corp的营收复合增速更高(36.8% vs -1.8%)
Apyx Medical前身是博维医疗,是美国的医疗器械制造商,专注生产电外科产品与能源技术相关医疗设备,公司总部位于佛罗里达州克利尔沃特,在保加利亚设有生产工厂。
3M是美国知名跨国综合企业,业务覆盖工业、劳动者安全防护、消费品等多个领域,总部位于圣保罗郊区的枫木市。公司现有超6万款产品,涵盖胶粘剂、研磨材料、防火防护产品、个人防护装备、窗膜、车漆保护膜、电子连接绝缘材料、汽车养护产品、光学膜等品类。
APYX vs MMM — 直观对比
营收规模更大
MMM
是对方的314.7倍
$19.2M
营收增速更快
APYX
高出33.4%
1.3%
净利率更高
MMM
高出17.6%
-6.8%
自由现金流更多
MMM
多$2.0B
$-2.8M
两年增速更快
APYX
近两年复合增速
-1.8%
损益表 — Q4 2025 vs Q1 2026
| 指标 | ||
|---|---|---|
| 营收 | $19.2M | $6.0B |
| 净利润 | $-1.3M | $653.0M |
| 毛利率 | 62.6% | 40.7% |
| 营业利润率 | 0.1% | 23.2% |
| 净利率 | -6.8% | 10.8% |
| 营收同比 | 34.7% | 1.3% |
| 净利润同比 | 71.9% | -41.5% |
| 每股收益(稀释后) | — | $1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APYX
MMM
| Q1 26 | — | $6.0B | ||
| Q4 25 | $19.2M | $6.1B | ||
| Q3 25 | $12.9M | $6.5B | ||
| Q2 25 | $11.4M | $6.3B | ||
| Q1 25 | $9.4M | $6.0B | ||
| Q4 24 | $14.2M | $6.0B | ||
| Q3 24 | $11.5M | $6.3B | ||
| Q2 24 | $12.1M | $6.3B |
净利润
APYX
MMM
| Q1 26 | — | $653.0M | ||
| Q4 25 | $-1.3M | $577.0M | ||
| Q3 25 | $-2.0M | $834.0M | ||
| Q2 25 | $-3.8M | $723.0M | ||
| Q1 25 | $-4.2M | $1.1B | ||
| Q4 24 | $-4.6M | $728.0M | ||
| Q3 24 | $-4.7M | $1.4B | ||
| Q2 24 | $-6.6M | $1.1B |
毛利率
APYX
MMM
| Q1 26 | — | 40.7% | ||
| Q4 25 | 62.6% | 33.6% | ||
| Q3 25 | 64.4% | 41.8% | ||
| Q2 25 | 62.3% | 42.5% | ||
| Q1 25 | 60.1% | 41.6% | ||
| Q4 24 | 63.0% | 51.7% | ||
| Q3 24 | 60.5% | 42.1% | ||
| Q2 24 | 61.7% | 42.9% |
营业利润率
APYX
MMM
| Q1 26 | — | 23.2% | ||
| Q4 25 | 0.1% | 13.0% | ||
| Q3 25 | -6.5% | 22.2% | ||
| Q2 25 | -22.6% | 18.0% | ||
| Q1 25 | -32.4% | 20.9% | ||
| Q4 24 | -21.4% | 12.2% | ||
| Q3 24 | -31.6% | 20.9% | ||
| Q2 24 | -45.7% | 20.3% |
净利率
APYX
MMM
| Q1 26 | — | 10.8% | ||
| Q4 25 | -6.8% | 9.4% | ||
| Q3 25 | -15.4% | 12.8% | ||
| Q2 25 | -33.2% | 11.4% | ||
| Q1 25 | -44.0% | 18.7% | ||
| Q4 24 | -32.5% | 12.1% | ||
| Q3 24 | -40.9% | 21.8% | ||
| Q2 24 | -54.0% | 18.3% |
每股收益(稀释后)
APYX
MMM
| Q1 26 | — | $1.23 | ||
| Q4 25 | — | $1.07 | ||
| Q3 25 | — | $1.55 | ||
| Q2 25 | — | $1.34 | ||
| Q1 25 | — | $2.04 | ||
| Q4 24 | — | $1.33 | ||
| Q3 24 | — | $2.48 | ||
| Q2 24 | $-0.19 | $2.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $3.7B |
| 总债务越低越好 | $37.5M | $10.9B |
| 股东权益账面价值 | $14.5M | $3.3B |
| 总资产 | $66.8M | $35.4B |
| 负债/权益比越低杠杆越低 | 2.58× | 3.29× |
8季度趋势,按日历期对齐
现金及短期投资
APYX
MMM
| Q1 26 | — | $3.7B | ||
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — |
总债务
APYX
MMM
| Q1 26 | — | $10.9B | ||
| Q4 25 | $37.5M | $12.6B | ||
| Q3 25 | $37.5M | $12.6B | ||
| Q2 25 | $37.5M | $13.1B | ||
| Q1 25 | $37.5M | $13.5B | ||
| Q4 24 | $37.5M | $13.0B | ||
| Q3 24 | $37.5M | $13.2B | ||
| Q2 24 | — | $13.1B |
股东权益
APYX
MMM
| Q1 26 | — | $3.3B | ||
| Q4 25 | $14.5M | $4.7B | ||
| Q3 25 | $5.8M | $4.6B | ||
| Q2 25 | $7.3M | $4.3B | ||
| Q1 25 | $10.5M | $4.5B | ||
| Q4 24 | $14.2M | $3.8B | ||
| Q3 24 | $11.0M | $4.6B | ||
| Q2 24 | $14.7M | $3.9B |
总资产
APYX
MMM
| Q1 26 | — | $35.4B | ||
| Q4 25 | $66.8M | $37.7B | ||
| Q3 25 | $57.4M | $37.6B | ||
| Q2 25 | $58.2M | $38.0B | ||
| Q1 25 | $60.2M | $40.0B | ||
| Q4 24 | $64.8M | $39.9B | ||
| Q3 24 | $60.7M | $40.9B | ||
| Q2 24 | $65.4M | $43.4B |
负债/权益比
APYX
MMM
| Q1 26 | — | 3.29× | ||
| Q4 25 | 2.58× | 2.68× | ||
| Q3 25 | 6.41× | 2.72× | ||
| Q2 25 | 5.17× | 3.06× | ||
| Q1 25 | 3.57× | 3.02× | ||
| Q4 24 | 2.64× | 3.40× | ||
| Q3 24 | 3.40× | 2.84× | ||
| Q2 24 | — | 3.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.5M | — |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $2.0B |
| 自由现金流率自由现金流/营收 | -14.6% | 33.6% |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.1M | $3.7B |
8季度趋势,按日历期对齐
经营现金流
APYX
MMM
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $1.6B | ||
| Q3 25 | $-3.5M | $1.8B | ||
| Q2 25 | $-1.2M | $-954.0M | ||
| Q1 25 | $-702.0K | $-79.0M | ||
| Q4 24 | $-2.9M | $1.8B | ||
| Q3 24 | $-4.4M | $-1.8B | ||
| Q2 24 | $-4.3M | $1.0B |
自由现金流
APYX
MMM
| Q1 26 | — | $2.0B | ||
| Q4 25 | $-2.8M | $1.3B | ||
| Q3 25 | $-4.1M | $1.5B | ||
| Q2 25 | $-1.5M | $-1.2B | ||
| Q1 25 | $-757.0K | $-315.0M | ||
| Q4 24 | $-3.2M | $1.5B | ||
| Q3 24 | $-4.6M | $-2.0B | ||
| Q2 24 | $-4.6M | $752.0M |
自由现金流率
APYX
MMM
| Q1 26 | — | 33.6% | ||
| Q4 25 | -14.6% | 21.8% | ||
| Q3 25 | -31.5% | 23.6% | ||
| Q2 25 | -13.2% | -18.3% | ||
| Q1 25 | -8.0% | -5.3% | ||
| Q4 24 | -22.4% | 25.4% | ||
| Q3 24 | -40.0% | -32.3% | ||
| Q2 24 | -38.0% | 12.0% |
资本支出强度
APYX
MMM
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 4.0% | ||
| Q3 25 | 4.0% | 3.3% | ||
| Q2 25 | 2.3% | 3.3% | ||
| Q1 25 | 0.6% | 4.0% | ||
| Q4 24 | 1.7% | 4.8% | ||
| Q3 24 | 1.3% | 3.9% | ||
| Q2 24 | 2.4% | 4.3% |
现金转化率
APYX
MMM
| Q1 26 | — | — | ||
| Q4 25 | — | 2.74× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | -1.32× | ||
| Q1 25 | — | -0.07× | ||
| Q4 24 | — | 2.50× | ||
| Q3 24 | — | -1.30× | ||
| Q2 24 | — | 0.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APYX
暂无分部数据
MMM
| Safety and Industrial business segment | $2.9B | 49% |
| Transportation and Electronics business segment | $1.8B | 31% |
| Consumer business segment | $1.1B | 19% |
| Corporate | $121.0M | 2% |